Free shipping on all orders over $ 500

SY-5609

Cat. No. M10966

All AbMole products are for research use only, cannot be used for human consumption.

SY-5609 Structure
Synonym:

CDK7-IN-3

Size Price Availability Quantity
1mg USD 175 In stock
5mg USD 440 In stock
10mg USD 710 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SY-5609 (CDK7-IN-3) is an orally active, highly selective, noncovalent CDK7 inhibitor with a KD of 0.065 nM. SY-5609 shows poor inhibition on CDK2 (Ki=2600 nM), CDK9 (Ki=960 nM), CDK12 (Ki=870 nM). SY-5609 induces apoptosis in tumor cells and has antitumor activity.

SY-5609 (100-500 nM; 48 hours) induces G2/M cell cycle arrest in HCC70 cells. SY-5609 (25-500 nM; 6-48 hours) results in inhibition of the phosphorylation of CDK2 at Thr160 via loss of CAK function for 24 and 48 h. SY-5609 (126.4 pM-4 µM; 72 hours) has an EC50 of 5.6 nM in HCC70 cell line.

In vivo, SY-5609 (2 mg/kg/day; orally; for 21 days) induces tumor regression over the 21-day dosing period.

Chemical Information
Molecular Weight 490.46
Formula C23H26F3N6OP
CAS Number 2417302-07-7
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage 4°C, sealed
References

[1] Jason J Marineau, et al. J Med Chem. Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7

[2] Hanzhi Liang, et al. Expert Opin Investig Drugs. Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy

[3] Georgina P Sava, et al. Cancer Metastasis Rev. CDK7 inhibitors as anticancer drugs

Related CDK Products
AT7519

AT7519 is a novel small molecule multi-cyclin-dependent (CDK) kinase inhibitor.

Flavopiridol

Flavopiridol (Alvocidib) is a competitive broad-spectrum CDK inhibitor with IC50 of 30,170,100 nM against CDK1, CDK2 and CDK4, respectively.

R547

R547 is a potent and selective ATP-competitive CDK inhibitor, with Ki values of 2 nM, 3 nM and 1 nM for CDK1/cyclin B, CDK2/cyclin E and CDK4/cyclin D1, respectively.

JNJ-7706621

JNJ-7706621 is a dual cell cycle inhibitor with activity against cyclin-dependent kinases (CDK1, 2, 3, 6) with an IC50 of 3-175 nM and Aurora kinases (A and B) with an IC50 of 11-15 nM respectively.

PD 0332991 HCL

PD-0332991 HCl is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays, respectively. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc.

  Catalog
Abmole Inhibitor Catalog




Keywords: SY-5609, CDK7-IN-3 supplier, CDK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.